Defects in Doubt Manufacturing: The Trajectory of a Pro-industrial Argument in the Struggle for the Definition of Carcinogenic Substances (September 2021)
Valentin Thomas (Author)
Science, Technology, and Human Values
Volume: 46
Issue: 5
Pages: 998-1020
Publication date: September 2021
Language: English
Edition Details: Special Issue: Beyond the Production of Ignorance: The Pervasiveness of Industry Influence through the Tools of Chemical Regulation
Recent work in science and technology studies has looked at how chemical industries manufacture doubt about the toxicity of their products and manage to establish their scientific views in the field of international regulations on toxic substances. Rather than examining yet another “victory” for the industry, this article analyzes the deployment of a “pro-industrial” scientific position, punctuated mainly by failure and opposition. This trajectory is tracked through the analysis of several data sets: archives, scientific documentation, and sociological interviews. The first part of the article charts the development of a biochemical concept, “peroxisome proliferation,” within an academic subfield and its subsequent appropriation by certain industrial parties who used it as a defensive weapon for their commercial interests. Through the example of the International Agency for Research on Cancer and its network of interdependent institutions, the article goes on to analyze the multiple attempts of chemical industry players to establish their interpretation of the concept within the regulatory bodies for carcinogenic substances. The study of such systems of sociological interdependence shows that a full analysis of the “doubt manufacturing” requires an examination not only of the manufacturing process but also of the reception of the ideas produced.
...MoreArticle Emmanuel Henry; Valentin Thomas; Sara Angeli Aguiton; Marc-Olivier Déplaude; Nathalie Jas (September 2021) Introduction: Beyond the Production of Ignorance: The Pervasiveness of Industry Influence through the Tools of Chemical Regulation. Science, Technology, and Human Values (pp. 911-924).
Similar Citations
Article
Colleen Lanier-Christensen;
(September 2021)
Creating Regulatory Harmony: The Participatory Politics of OECD Chemical Testing Standards in the Making
(/p/isis/citation/CBB606231580/)
Article
Emmanuel Henry;
Valentin Thomas;
Sara Angeli Aguiton;
Marc-Olivier Déplaude;
Nathalie Jas;
(September 2021)
Introduction: Beyond the Production of Ignorance: The Pervasiveness of Industry Influence through the Tools of Chemical Regulation
(/p/isis/citation/CBB736985993/)
Book
David J. Hess;
(2016)
Undone Science: Social Movements, Mobilized Publics, and Industrial Transitions
(/p/isis/citation/CBB272081586/)
Article
Henri Boullier;
Emmanuel Henry;
(2022)
Toxic Ignorance: How Regulatory Procedures and Industrial Knowledge Jeopardise the Risk Assessment of Chemicals
(/p/isis/citation/CBB183545703/)
Article
Angela N. H. Creager;
(September 2021)
To Test or Not to Test: Tools, Rules, and Corporate Data in US Chemicals Regulation
(/p/isis/citation/CBB745420064/)
Article
Armon, Rony;
(2012)
From Pathology to Chemistry and Back: James W. Cook and Early Chemical Carcinogenesis Research
(/p/isis/citation/CBB001210098/)
Book Christian Marx; Wegbereiter der Globalisierung. Multinationale Unternehmen der westeuropäischen Chemieindustrie (1960er-2000er Jahre) (/p/isis/citation/CBB844007122/)
Article
Mark A. Murphy;
(2023)
Professors Trost and Sheldon's Promotion of Catalytic Technologies, Atom Economy, and the E-Factor Metrics in Synthetic Organic Chemistry and the Fine Chemical and Pharmaceutical Industries, to Speed the Early Evolution of "Green Chemistry"
(/p/isis/citation/CBB123483490/)
Book
Ralf Banken;
Raymond G. Stokes;
(2014)
Aus der Luft gewonnen: Die Entwicklung der globalen Gaseindustrie 1880 bis 2012
(/p/isis/citation/CBB988002372/)
Article
Kodama, Yoichi;
Fujimura, Shuzo;
(2011)
Technology Diffusion in a Chemical Company: A Case Study on the Development of Surface Protection Tape for Semiconductor Wafer in Mitsui Chemicals, Inc.
(/p/isis/citation/CBB001220684/)
Article
Maite P. Salazar;
Daniel Valenzuela;
Manuel Tironi;
Rodrigo A. Gutiérrez;
(2019)
The ambivalent regulator: The construction of a regulatory style for genetically modified crops in Chile
(/p/isis/citation/CBB036000701/)
Article
Alina Geampana;
(2019)
Risky Technologies: Systemic Uncertainty in Contraceptive Risk Assessment and Management
(/p/isis/citation/CBB376759289/)
Article
Margaret Sleeboom-Faulkner;
(June 2019)
Regulatory brokerage: Competitive advantage and regulation in the field of regenerative medicine
(/p/isis/citation/CBB470996355/)
Article
Sarah Wadmann;
Amalie Martinus Hauge;
(August 2021)
Strategies of stratification: Regulating market access in the era of personalized medicine
(/p/isis/citation/CBB940730003/)
Article
Katherine W. Darling;
Angie M. Boyce;
Mildred K. Cho;
Pamela L. Sankar;
(January 2015)
'What Is the FDA Going to Think?' Negotiating Values through Reflective and Strategic Category Work in Microbiome Science
(/p/isis/citation/CBB106248451/)
Article
Schleifer, David;
(February 2013)
Categories count: Trans fat labeling as a technique of corporate governance
(/p/isis/citation/CBB214363773/)
Article
Christopher L. Cummings;
Agnes S. F. Chuah;
Shirley S. Ho;
(September 2018)
Protection Motivation and Communication through Nanofood Labels: Improving Predictive Capabilities of Attitudes and Purchase Intentions toward Nanofoods
(/p/isis/citation/CBB867911612/)
Article
Klaus Hoeyer;
(July 2015)
Regulatory Anatomy: How “Safety Logics” Structure European Transplant Medicine
(/p/isis/citation/CBB387324455/)
Article
Judy Z Segal;
(August 2018)
Sex, drugs, and rhetoric: The case of flibanserin for ‘female sexual dysfunction’
(/p/isis/citation/CBB311917478/)
Article
Poonam Pandey;
Aviram Sharma;
(2017)
NGOs, Controversies, and “Opening Up” of Regulatory Governance of Science in India
(/p/isis/citation/CBB915250388/)
Be the first to comment!